# Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue

> **NCT07276854** · — · NOT_YET_RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 32 (estimated)

## Conditions studied

- Gastric Cancer
- Molecular Imaging

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic Test: ICG-FTn perfusion solution

## Key facts

- **NCT ID:** NCT07276854
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-08-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07276854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07276854, "Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT07276854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*